← Open Payments lookup

KAI ANDREWS: Open Payments

NPI 1659848760 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$881 in 12 payments from 9 companies in 2025. Trend: 2023 $1,381 · 2024 $443 · 2025 $881

Food & beverage: $881
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$249
Daiichi Sankyo Inc.2$154
Kite Pharma, Inc.1$122
Takeda Pharmaceuticals U.S.A., Inc.1$110
Janssen Biotech, Inc.1$89
Ipsen Biopharmaceuticals, Inc1$88
Merck Sharp & Dohme LLC1$25
Novartis Pharmaceuticals Corporation1$23
PUMA BIOTECHNOLOGY, INC.1$21

Products named: DATROWAY, FRUZAQLA, RYBREVANT, Onivyde, Enhertu, KEYTRUDA, KISQALI, NERLYNX.

Industry payments across MD — which companies pay providers there.